The CCL18 serum level in patients with squamous cell carcinoma was higher than in sera from patients with adenocarcinoma (187(857) ng/ml, 143(528) ng/ml; respectively; p<0.02). This evidence concerns the gene CCL18 and adenocarcinoma.